TGTX - TG Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TGTX is currently covered by 8 analysts with an average price target of $46.66. This is a potential upside of $11.59 (33.05%) from yesterday's end of day stock price of $35.07.

TG Therapeutics's activity chart (see below) currently has 49 price targets and 82 ratings on display. The stock rating distribution of TGTX is 81.4% BUY, 9.3% SELL and 9.3% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.6% with an average time for these price targets to be met of 288.17 days.

Highest price target for TGTX is $55, Lowest price target is $22, average price target is $46.66.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 05-Nov-2024. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of TGTX, 35 are a BUY (81.4%), 4 are a SELL (9.3%), 4 are a HOLD (9.3%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$55

$25.46 (86.19%)

$49

17 days ago
(05-Nov-2024)

9/18 (50%)

$30.72 (126.52%)

243

Hold

$22

$-7.54 (-25.52%)

$20

17 days ago
(05-Nov-2024)

5/8 (62.5%)

$-2.28 (-9.39%)

147

Buy

$34

$4.46 (15.10%)

$29

3 months 15 days ago
(07-Aug-2024)

12/14 (85.71%)

$14.01 (70.09%)

245

Buy

$25

$-4.54 (-15.37%)

$23

7 months 4 days ago
(18-Apr-2024)

6/6 (100%)

$11.01 (78.70%)

203

Buy

$24

$-5.54 (-18.75%)

$24

1 years 7 months 5 days ago
(17-Apr-2023)

2/3 (66.67%)

$3.45 (16.79%)

46

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TGTX (TG Therapeutics) average time for price targets to be met?

On average it took 288.17 days on average for the stock forecasts to be realized with a an average price target met ratio 68.6

Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on TGTX (TG Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 9 price targets and 6 ratings on TGTX

Which analyst is the currently most bullish on TGTX (TG Therapeutics)?

Matthew Kaplan with highest potential upside - $54.89

Which analyst is the currently most reserved on TGTX (TG Therapeutics)?

Alec Stranahan with lowest potential downside - -$23.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?